Latest filing published 09 Feb 2022 for Cardiovascular Systems Inc.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Ryan Egeland: trading record in brief
All filings by Ryan Egeland on record concern Cardiovascular Systems Inc, in the capacity of senior executive. The record holds 16 filings, for trades running from 9 August 2019 to 8 February 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 9 February 2022, reports a share grant in Cardiovascular Systems Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ryan Egeland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,477 shares0Common StockSEC:0001437749-22-002882:0
- 1,107 shares0Common StockSEC:0000914190-21-000292:0
- 1,820 shares@ US$36.07100.0% of flowCommon StockSEC:0000914190-21-000277:0
- 4,438 shares0Common StockSEC:0000914190-21-000240:0
4 of 4 declarations
